|
Oct 9
|
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
|
|
Sep 30
|
September 2024's UK Stock Picks For Possible Value Investing
|
|
Sep 26
|
Smith & Nephew (LON:SN.) May Have Issues Allocating Its Capital
|
|
Aug 26
|
3 UK Stocks That Could Be Trading Up To 40.7% Below Intrinsic Value Estimates
|
|
Aug 25
|
Can Smith & Nephew plc's (LON:SN.) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?
|
|
Jul 30
|
Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
|
|
Jul 24
|
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
|
|
Jul 24
|
Admiral Group And 2 More UK Exchange Stocks Estimated As Below Intrinsic Value
|
|
Jul 17
|
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
|
|
Jul 16
|
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
|
|
Jun 26
|
Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game
|
|
Jun 24
|
June 2024 Insights Into UK Stocks Estimated To Be Undervalued
|
|
Jun 12
|
Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
|
|
May 8
|
An Intrinsic Calculation For Smith & Nephew plc (LON:SN.) Suggests It's 34% Undervalued
|
|
Apr 22
|
With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
|
|
Apr 18
|
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
|
|
Apr 8
|
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
|
|
Apr 8
|
Here’s Why You Should Invest in Smith & Nephew plc (SNN)
|
|
Apr 4
|
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
|
|
Apr 3
|
Investors five-year losses continue as Smith & Nephew (LON:SN.) dips a further 5.6% this week, earnings continue to decline
|